SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 35 of 37
Finance
Pfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By
Stephen Gandel
November 24, 2015
Finance
Investors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By
Stephen Gandel
November 23, 2015
Finance
Will the Pfizer Inversion Get It Booted From the Dow?
By
Chris Matthews
November 23, 2015
Finance
Pfizer/Allergan deal pushes 2015 into the record books
By
Dan Primack
November 23, 2015
Health
Prediction: Healthcare’s M&A Flood Will Ebb in 2016
By
Jen Wieczner
November 23, 2015
Finance
Why New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By
Stephen Gandel
November 20, 2015
Leadership
Will Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By
Paul Hodgson
November 20, 2015
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By
Jen Wieczner
November 19, 2015
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By
Alan Murray
November 19, 2015
Tech
VW’s New Horror And Facebook 3Q–5 Things To Know Today
By
Laura Lorenzetti
and
Geoffrey Smith
November 4, 2015
Finance
Pfizer-Allergan could be a super inversion deal
By
Stephen Gandel
October 29, 2015
Features
Gunboat diplomacy and Apple earnings — 5 things to know today
By
Tom Huddleston Jr.
October 27, 2015
Features
Apple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By
Tom Huddleston Jr.
October 25, 2015
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By
Chris Matthews
August 7, 2015
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By
Tom Huddleston Jr.
July 7, 2015
Most Popular
Banking
Markets expected the rate cut, but the ‘real surprise’ is the Fed’s opinion on the current state of the economy, quant...
By
Amanda Gerut
Success
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
By
Emma Burleigh
Law
Publishers Clearing House, company that promised 'forever' payments to sweepstakes winners, says actually nevermind
By
The Associated Press